Market Research Future (MRFR) publishes periodic market research reports Nuclear Imaging Devices Market Research Report - Global Forecast till 2024 on niche and emerging technologies.
The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.
The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.
Segmentation
The global Nuclear Imaging Devices Market size is segmented based on technology, application, end user, and region.
The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.
Based on application, the market is segmented into oncology, cardiology, neurology, and others.
Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.
The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.
Intended Audience
- Medical devices companies
- Government and private laboratories
- Research and development (R&D) companies
- Research laboratories
- Market research and consulting service providers
Global Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Global Forecast till 2024. For more info visit @https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014
Key Players
Some of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Global Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Global Forecast till 2024Market HighlightsThe global nuclear imaging devices market is expected to grow significantly over the forecast period.
It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market.
As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.Intended AudienceMedical devices companiesGovernment and private laboratoriesResearch and development (R) companiesResearch laboratoriesMarket research and consulting service providersAvail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8014 However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.SegmentationThe global nuclear imaging devices market is segmented based on technology, application, end user, and region.The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy.
The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.Based on application, the market is segmented into oncology, cardiology, neurology, and others.Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.Key PlayersSome of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.Regional AnalysisIn the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.The nuclear imaging devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe.
Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
Dental Surgical & Diagnostic Devices Market Research Report: By Product Type (Cad/Cam Systems, Dental Chairs, Dental Radiology Devices, Cbct Scanners, Scaling Units, Dental Lasers), By Application (Bone Abnormalities, Cysts, Fractures, Reconstructive Postmortem Dental Profiling, and Comparative Dental Identification), By End Users (Dentists, Hospitals, Others) - Global Forecast till 2027Market ScenarioDental surgical and diagnostic devices are the medical devices used for the diagnosis and the treatment of the dental problems.
Increasing prevalence of dental problems, rising geriatric population, development in the dental surgical and diagnostic devices drive the global market.
The global dental surgical and diagnostic devices market is expecting a sound growth at a health CAGR of 11.2% during the forecasted period.
According to the National Institute of Dental and Craniofacial Research (2016), in America, 80% of the adults aged 20 - 64 years have dental cavity or tooth decay.
Furthermore, high spending on healthcare and well-developed infrastructure have also help in the growth of the market.
(Germany), Ivoclar Vivadent, Inc. (Liechtenstein), Hu-Friedy Mfg.
Global Ascites Market: Information by Types (Transudative Ascites and Exudate Ascites), Diagnosis (Ultrasound, CT Scan, Laparoscopy and Angiography), Treatment (Surgeries), End Users (Hospitals & Clinics, Ambulatory Surgical Center and Diagnostic Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027Market HighlightsAscites is the accumulation of fluid in the spaces between the abdomen and abdominal organs.
Other conditions that can cause ascites include hepatitis B, hepatitis C, congestive heart failure, kidney disease, and malignancyIncreasing prevalence of cirrhosis, favorable reimbursement scenario, rising occurrence of cancer, development of new drugs, and technological improvements are the key factors driving the ascites market.However, complications associated with ascites treatment may hinder the growth of the market to an extent.
Various complications have been observed with ascites treatment approaches such as bleeding, small bowel perforation, stent placement complications, post-procedural complexities, and others.
Some of these complications are rare and life-threateningThe global ascites market is expected to grow at a CAGR of 4.0% during the forecast period 2017-2023.Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report.
Avail the in-depth table of content TOC & market synopsis on “ascites market research report–Global forecast till 2023.” Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1909Key Players in the Ascites MarketSome of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.Regional AnalysisThe Americas dominate the ascites market owing to the well-developed technology, high healthcare expenditure, rising prevalence of cirrhosis, and the presence of the leading players.
It is also stated that from 2000 to 2015 death rates due to the chronic liver disease and cirrhosis increased by 31% in the United States among individuals aged 45–64 years.Europe holds the second position in the ascites market.
Market Highlights:Global Blood Collection Market Research Report: by Type of blood collection (capillary, venous, vacuum), by product (blood collection devices, blood collection tubes, needles and syringes, lancets), by method (automated, manual), end user – Forecast Till 2023The Global Blood Collection Market is expected to grow at a CAGR of 6.1% during the forecast period.
Increasing prevalence of chronic conditions, advancements in healthcare facilities, and favorable funding policies are expected to drive the market growth over the forecast period.
According to the World Health Organization (WHO), there are over 35 Million healthcare workers and these workers face an increased risk of infection from blood-borne pathogens simply because of their exposure to blood and other body fluids.
However, blood contamination and injury caused by blood collection devices can restrain the market growth over the assessment period.Key Players:Some of the prominent players in the global blood collection market-BD, Medtronic, Terumo, Haemonetics, Fresenius, Nipro Medical, Kawasumi Laboratories, F.L.
Medical, Greiner Holding, Grifols, B. Braun Melsungen AG, Thermo Fisher Scientific Inc., HTL-STREFA S.A., Sarstedt AG & Co and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7013 Segmentation:The Global Blood Collection Market has been segmented into type of blood collection, product, method, and end user.The market, on the basis of type of blood collection, has been segmented into capillary blood collection, venous blood collection, and vacuum blood collection.The market, by product, has been segmented into blood collection devices, blood collection tubes and collector, needles and syringes, warming devices, blood bags, lancets, and others.
The blood collection tubes and collector segment is further classified as serum collection tubes, and plasma or whole blood collection tubes.
Overview:The global body composition analyzers market would reach a valuation of USD 768.59 million by 2025 with a 7.6% CAGR during the forecast period (2019-2025).
Market Research Future (MRFR) revealed that factors like growing inclusion of the system to measure fitness in various sports training facilities would inspire market growth.
Also, the hike in investment in research facilities would help the market gain prominence during the forecast period.
With the booming fitness industry and awareness regarding weight loss programs, this market would gain better prospects.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/8473The market would further profit from the rise in the number of obese people, better initiatives taken by the government, the inclusion of cost-effective procedures, and others.But the market for the body composition analyzers has a chance of losing out due to inconsistent results.Segmentation:The global market report on the body composition analyzers holds various details regarding the market factors and dynamics in play that can establish a strong growth rate.
Regional Analysis:The global report on the body composition analyzers market has several demographic insights and inputs to provide a better view of various growth pockets that can be used in the coming years to develop enriched strategies.
The Americas is helming the market where the US and Canada are making significant contributions.
Market HighlightsA swollen knee arises when surplus fluid accumulates in or around your knee joint.
A swollen knee may be a consequence of overuse injuries, or trauma, and an underlying disease or condition.
Serious complications such as blood clots, knee joint infections can be restraining factors for the growth of the market.SegmentationThe global swollen knee treatment market has been segmented on the basis of type and end-users.
On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.Access Report @ https://www.marketresearchfuture.com/reports/swollen-knee-treatment-market-6406Regional AnalysisThe Americas is projected to lead the swollen knee treatment market in the forecast period.
Rising rate in a number of surgeries due to factors such as accidents, injuries, and others contribute majorly to the growth of the market.
Increasing healthcare awareness, advancement in technology, medical tourism, and an increase in disposable income are some other factors that boost the growth of the market.The European market is expected to hold the second largest market share as osteoarthritis is most common in Germany.
